Chimeric mammalian NPY Y.sub.5 receptors

Details Chimeric mammalian NPY Y.sub.5 receptors Chimeric mammalian NPY Y.sub.5 receptors

1998-01-07

1999-11-16

Teng, Sally P.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

4352523, 43525411, 4353201, 435325, 536 234, 536 235, C12N 1562

Patent

active

059856165

ABSTRACT:
The present invention provides mammalian chimeric NPY Y.sub.5 receptors, nucleic acids and vectors encoding the receptors, methods for making the receptors, fragments or fusion proteins thereof using recombinant DNA methodology or chemical synthesis, and methods for using the receptors in screening systems to identify compounds for the treatment of various diseases.

REFERENCES:
patent: 5602024 (1997-02-01), Gerald
Wilding, J., et al., (1993), Increased Neuropeptide-Y Messenger Ribonucleic Acid (mRNA) and Decreased Neurotensin mRNA in the Hypothalamus of the Obese (ob/ob) Mouse, Endocrinology, vol. 132, pp. 1939-1944.
Woldbye, D., et al., (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors, Nature Medicine, vol. 3, pp. 761-764.
Gerald, C., et al., (1996), A receptor subtype involved in neuropeptide-Y-induced food intake, Nature, vol. 382, pp. 168-171.
Howlett, R., (1996), Prime Time for neuropeptide Y, Nature, vol. 382, p. 113.
Hu, Y., et al., (1966), Identificaiton of a Novel Hypothalamic Neuropeptide Y Receptor Associated with Feeding Behavior, The Journal of Biological Chemistry, vol. 271, pp. 26315-26319.
Sperk, G., et al., (1997), Anticonvulsant action of neuropeptide Y, Nature Medicine, vol. 3, pp. 728-729.
Stephens, T., et al., (1995), The role of neuropeptide Y in the antiobesity action of the obese gene product, Nature, vol. 377, pp. 530-532.
Wahlestedt, C., et al., (1993), Neuropeptide Y-Related Peptides and Their Receptors--Are the Receptors Potential Therapeutic Drug Targets?, Annual Reviews Pharmacol. Toxicol, , vol. 32, pp. 309-352.
Akabayashi, A., et al., (1994), Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats, Brain Research., vol., 665, pp. 202-212.
Bischoff, A., et al., (1997), Receptor subtypes Y.sub.1 and Y.sub.5 are involved in the renal effects of neuropeptide Y, British Journal of Pharmacology, vol. 120, pp. 1335-1343.
Blomqvist, A., et al., (1997), Y-receptor subtypes--how many more?, Trends Neurosci., vol. 20, pp. 294-298.
Cheng, Y., et al., (1973), Relationship Between the Inhibition Constant (K.sub.1) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibitor (I.sub.50) of an Enzymatic Reaction, Biochemical Pharmacology, vol. 22, pp. 3099-3108.
Dube, M., et al., (1994), Evidence that neuropeptide Y is a physiological signal for normal food intake, Brain Research, vol. 646, 341-344.
Erickson, J., et al., (1996), Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y, Science, vol. 274, pp. 1704-1707.

Affiliated with

Also associated with

Rating

Chimeric mammalian NPY Y.sub.5 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chimeric mammalian NPY Y.sub.5 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric mammalian NPY Y.sub.5 receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1323337